AMG 581

DRUG2 trials

Sponsors

Amgen

Conditions

Schizophrenia or Schizoaffective Disorder

Phase 1

Multiple Ascending Dose Study on Safety, Tolerability, and Pharmacokinetics of AMG 581 in Healthy Subjects or Subjects With Schizophrenia or Schizoaffective

CompletedNCT02504476

AmgenSchizophrenia or Schizoaffective Disorder

Start: 2015-08-31End: 2016-02-29Updated: 2016-03-07

Single-ascending Dose Study With a Food-Effect Cohort to Evaluate AMG 581

CompletedNCT02567370

AmgenSchizophrenia or Schizoaffective Disorder

Start: 2015-08-31End: 2015-10-31Updated: 2015-10-23